A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

Cirkel Geert A; Kerklaan Bojana Milojkovic; Vanhoutte Frederic; Van der Aa Annegret; Lorenzon Giocondo; Namour Florence; Pujuguet Philippe; Darquenne Sophie; de Vos Filip Y F; Snijders Tom J; Voest Emile E; Schellens Jan H M; Lolkema Martijn P

doi:10.1007/s10637-015-0320-9

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

作者：Cirkel Geert A; Kerklaan Bojana Milojkovic; Vanhoutte Frederic; Van der Aa Annegret; Lorenzon Giocondo; Namour Florence; Pujuguet Philippe; Darquenne Sophie; de Vos Filip Y F; Snijders Tom J; Voest Emile E; Schellens Jan H M; Lolkema Martijn P

来源：Investigational New Drugs, 2016, 34(2): 184-192.

DOI：10.1007/s10637-015-0320-9